N.F. Fitz, V. Tapias, A.A. Cronican, E.L. Castranio, M.
Saleem, A.Y. Carter, M. Lefterova, I. Lefterov, R. Koldamova.
Opposing effects of Apoe/Apoa1 double deletion on amyloid-β pathology and cognitive performance in APP mice. Brain. 2015 Dec;138(Pt 12):3699-715. doi: 10.1093/brain/awv293.
Fitz NF, Castranio EL, Carter AY, Kodali R, Lefterov I, Koldamova R.
Improvement of memory deficits and amyloid-β clearance in aged APP23 mice treated with a combination of anti-amyloid-β antibody and LXR agonist.
Journal of Alzheimer's Disease 2014 [Epub March 18]
DOI:10.3233/JAD-132789 PMID:24643138
Fitz NF, Cronican AA, Lefterov I, Koldamova R.
Comment on "ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models".
Science 2013; 340(6135):924-c.
DOI:10.1126/science.1235809 PMID:23704552
Fitz NF, Cronican AA, Saleem M, Fauq AH, Chapman R, Lefterov I, Koldamova R.
Abca1 deficiency affects Alzheimer's disease-like phenotype in human ApoE4 but not in ApoE3-targeted replacement mice.
Journal of Neuroscience 2012; 32(38):13125-13136.
DOI:10.1523/JNEUROSCI.1937-12.2012 PMID:22993429
Fitz NF, Cronican A, Pham T, Fogg A, Fauq AH, Chapman R, Lefterov I, Koldamova R.
Liver X receptor agonist treatment ameliorates amyloid pathology and memory deficits caused by high-fat diet in APP23 mice.
Journal of Neuroscience 2010; 30(20):6862-6872.
DOI:10.1523/JNEUROSCI.1051-10.2010 PMID:20484628